Scisparc Ltd (SPRC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $869,840
Last updated: Nov 17, 2026 at 10:58 AM ET
Scisparc Ltd (SPRC) Financials: Revenue, Profit and Cash Flow
Scisparc reported revenue of $856.00K for the fiscal year ended Dec 31, 2025, down 34.5% from the year before. That year, net income was -$12.18M with a net margin of -1422.8%, operating cash flow was -$4.14M and free cash flow was -$4.14M. The quarter ended Jun 30, 2026 had revenue of $284.00K and net income of -$5.37M.
Revenue and Margins
Over the 8 years to Dec 2025, revenue grew from $487.00K, a compound annual rate of 7.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $856.00K | -34.5% | 73.7% | -1022.1% | -1422.8% |
| Dec 2024 | $1.31M | -54.6% | 38.7% | -560.2% | -481.2% |
| Dec 2023 | $2.88M | +113.7% | 76.3% | -200.5% | -177.9% |
| Dec 2022 | $1.35M | +26.0% | 76.1% | -547.9% | -192.4% |
| Dec 2021 | $1.07M | +94.4% | 96.9% | -539.6% | -542.7% |
| Dec 2020 | $550.00K | +10.4% | 70.2% | -598.7% | -637.6% |
| Dec 2019 | $498.00K | -40.6% | 64.1% | -824.9% | -1076.7% |
| Dec 2018 | $838.00K | +72.1% | 82.5% | -1159.2% | -1017.1% |
| Dec 2017 | $487.00K | N/A | 99.0% | -1181.5% | -1282.1% |
| Dec 2016 | N/A | N/A | N/A | N/A | N/A |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $856.00K | $1.31M | $2.88M | $1.35M | $1.07M | $550.00K | $498.00K | $838.00K | $487.00K | N/A |
| Cost of revenue | $225.00K | $800.00K | $683.00K | $322.00K | $33.00K | $164.00K | $179.00K | $147.00K | $5.00K | N/A |
| Gross profit | $631.00K | $506.00K | $2.20M | $1.02M | $1.04M | $386.00K | $319.00K | $691.00K | $482.00K | N/A |
| Research and development | $2.19M | $1.81M | $1.64M | $2.80M | $1.99M | $649.00K | $1.64M | $2.71M | $2.02M | $738.83K |
| Operating income | -$8.75M | -$7.32M | -$5.77M | -$7.38M | -$5.77M | -$3.29M | -$4.11M | -$9.71M | -$5.75M | N/A |
| Net income | -$12.18M | -$6.28M | -$5.12M | -$2.59M | -$5.80M | -$3.51M | -$5.36M | -$8.52M | -$6.24M | N/A |
| EBITDA | N/A | -$6.97M | -$5.31M | -$2.35M | -$5.74M | -$2.39M | -$3.73M | -$6.93M | -$5.75M | -$2.00M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Sep 2025 | Mar 2025 | Sep 2024 | Mar 2024 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $284.00K | $395.00K | $461.00K | $466.00K | $840.00K | $907.00K | $1.97M | $1.35M | N/A | N/A | N/A | $1.07M |
| Gross profit | $212.00K | $226.00K | $171.00K | $32.00K | $474.00K | $323.00K | $705.00K | $1.02M | N/A | N/A | -$21.00K | $1.04M |
| Operating income | -$4.89M | $402.00K | -$9.15M | -$10.84M | $3.53M | $3.85M | -$2.97M | -$3.47M | N/A | N/A | -$4.81M | -$3.14M |
| Net income | -$5.37M | -$2.85M | -$9.33M | -$2.84M | -$3.44M | -$2.24M | -$2.88M | $3.17M | N/A | N/A | -$5.76M | -$3.14M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $366.00K by $4.22M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $7.62M | $10.35M | $11.18M | $10.61M | $9.92M | $2.56M | $1.15M | $4.56M | $9.57M | $1.24M |
| Current assets | $5.44M | $7.50M | $6.45M | $4.51M | $9.82M | $2.55M | $955.00K | $2.43M | $9.50M | $803.83K |
| Cash and equivalents | $4.59M | $1.54M | $2.08M | $3.57M | $6.88M | $1.95M | $870.00K | $1.49M | $9.20M | $675.40K |
| Total liabilities | $2.48M | $1.41M | $1.59M | $4.16M | $1.77M | $1.13M | $1.14M | $4.48M | $1.18M | $672.02K |
| Short-term debt | $366.00K | $37.00K | $52.00K | $27.00K | $486.00K | $188.00K | $406.00K | $1.15M | N/A | N/A |
| Shareholder equity | $4.24M | $8.15M | $7.61M | $6.45M | $8.14M | $1.43M | $14.00K | $185.00K | $8.13M | $572.71K |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $18.49M | $7.62M | $7.62M | $5.14M | $5.14M | $10.35M | $10.35M | $10.48M | $10.48M | $11.18M | $11.18M | $9.89M |
| Total liabilities | $7.22M | $2.48M | $2.48M | $5.22M | $5.22M | $1.41M | $1.41M | $1.83M | $1.83M | $1.59M | $1.59M | $3.11M |
| Cash and equivalents | $4.44M | $4.59M | $4.59M | $1.54M | $1.54M | $1.54M | $1.54M | $252.00K | $252.00K | $2.08M | $2.08M | $2.08M |
| Shareholder equity | $3.94M | $4.24M | $4.24M | -$782.00K | -$782.00K | $8.15M | $8.15M | $6.92M | $6.92M | $7.61M | $7.61M | $4.10M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4.14M | -$5.10M | -$5.89M | -$7.92M | -$5.06M | -$4.31M | -$4.70M | -$7.13M | -$4.58M | N/A |
| Capital expenditures | $0 | $0 | $0 | $4.87M | $35.00K | $35.00K | $1.00K | $17.00K | $44.00K | N/A |
| Free cash flow | -$4.14M | -$5.10M | -$5.89M | -$12.79M | -$5.10M | -$4.34M | -$4.70M | -$7.15M | -$4.62M | N/A |
| Investing cash flow | -$1.40M | -$1.63M | -$1.11M | -$7.08M | -$70.00K | $24.00K | $1.27M | -$2.09M | -$53.00K | N/A |
| Financing cash flow | $8.59M | $6.19M | $5.50M | $11.70M | $10.06M | $5.36M | $2.80M | $1.54M | $13.18M | $563.87K |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Sep 2025 | Mar 2025 | Sep 2024 | Mar 2024 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$3.56M | -$2.28M | -$1.86M | -$2.91M | -$2.20M | -$2.65M | -$3.23M | -$5.73M | -$2.86M |
| Capital expenditures | $0 | $0 | $0 | $1.00K | $1.00K | $0 | $0 | $8.00K | $4.00K |
| Free cash flow | -$3.56M | -$2.28M | -$1.86M | -$2.91M | -$2.20M | -$2.65M | -$3.23M | -$5.74M | -$2.87M |
Frequently Asked Questions About SPRC
What is Scisparc's annual revenue?
Scisparc reported revenue of $856.00K for the fiscal year ended Dec 31, 2025.
How fast is Scisparc's revenue growing?
Revenue was down 34.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -14.0%.
Is Scisparc profitable?
No. Scisparc reported net income of -$12.18M for the fiscal year ended Dec 31, 2025, with a net margin of -1422.8%.
How much free cash flow does SPRC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$4.14M minus capital expenditures of $0 produced free cash flow of -$4.14M.
How much debt does Scisparc have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $366.00K and cash and equivalents of $4.59M.
SPRC pages: Overview, Financials